Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia
Mette Levinsen, Diana Shabaneh, Cathrine Bohnstedt, Arja Harila-Saari, Olafur G. Jonsson, Jukka Kanerva, Anna Lindblom, Bendik Lund, Elisabeth Anne Wreford Andersen, Kjeld Schmiegelow
Dive into the research topics of 'Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia'. Together they form a unique fingerprint.